Results 211 to 220 of about 63,797 (281)

The urgent need for African research collaboration on medicine quality. [PDF]

Nat Commun
Zeng F, Mariwah S, Mshana G, Amoako-Sakyi D, Hamill H.   +4 more
europepmc   +1 more source

Malaria in Children at 9 US Hospitals: 2016-2023. [PDF]

Pediatrics
Sundararaman SA, Roper B, Davis AKF, Hanze Villavicencio KL, Mayhew JA, Wang ML, Tang NL, Soma VL, Wang Z, Feeney ME, Trehan I, Weatherhead JE, John CC, Gerber JS, Odom John AR.   +14 more
europepmc   +1 more source

Asymptomatic malaria: a hidden reservoir for the transmission and circulation of artemisinin partial-resistant <i>Plasmodium falciparum</i> in Tanzania. [PDF]

Emerg Microbes Infect
Mazigo E, Lee WJ, Jun H, Fitriana F, Syahada JH, Louis JM, Muh F, Lu F, Lee KJ, Nam JW, Han JH, Kwon TH, Lee SJ, Na S, Chun W, Park WS, Han ET, Todd J, Manjurano A, Kidima W, Han JH.   +20 more
europepmc   +1 more source

Benzoxaboroles Are Inhibitors of the η-Class Carbonic Anhydrase From Plasmodium falciparum. [PDF]

Arch Pharm (Weinheim)
Bonardi A, Wein S, Mustafa M, Cerdan R, de Luca V, Capasso C, Gratteri P, Supuran CT, Nocentini A, Winum JY.   +9 more
europepmc   +1 more source

A Rare Case of Acute Hemolysis After Rasburicase Infusion. [PDF]

J Adv Pract Oncol
Broadway-Duren JB, Gardiner TP.
europepmc   +1 more source

Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort

Lupus, 2018
This longitudinal retrospective study aims at describing the safety profile and the reasons for discontinuation of antimalarials in patients with systemic lupus erythematosus (SLE) and discoid lupus erythematosus (DLE), focusing on ocular toxicity.
Francesca Romana Spinelli, Fulvia Ceccarelli, Carlo Perricone   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic

Annals of the Rheumatic Diseases, 2020
I read with great interest the letter by Spinelli et al published in the Annals of the Rheumatic Diseases .1 The authors describe the existing scientific evidence concerning the potential antiviral activity of chloroquine and hydroxychloroquine (HCQ ...
K. Parperis
semanticscholar   +1 more source

Antimalarials

Dermatologic Therapy, 2001
Antimalarial medications have become the parenteral drugs of choice for treating the cutaneous manifestations of lupus erythematosus. The immune-modulating activity of these agents makes them useful in a variety of other dermatoses. With prudent dosage and monitoring, these agents can be used safely and effectively in the treatment and management of ...
M J, Van Beek, W W, Piette
openaire   +2 more sources

An Overview of Available Antimalarials: Discovery, Mode of Action and Drug Resistance.

Current molecular medicine, 2020
Malaria is one of the three most deadly infectious diseases in the world and seriously endangers human health and life. To reduce the public health burden of this disease, scientists have focused on the discovery and development of effective antimalarial
Yu-Qing Tang, Q. Ye, He Huang, Weiyi Zheng   +3 more
semanticscholar   +1 more source